Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$15.5M Buy
991,207
+30,768
+3% +$457K 0.13% 104
2022
Q3
$13M Buy
960,439
+43,651
+5% +$521K 0.13% 99
2022
Q2
$9.12M Buy
916,788
+6,360
+0.7% +$78.6K 0.09% 116
2022
Q1
$13.1M Buy
+910,428
New +$12.5M 0.11% 111
2021
Q4
Sell
-754,141
Closed -$14.9M 541
2021
Q3
$14.9M Buy
754,141
+4,482
+0.6% +$102K 0.12% 101
2021
Q2
$19.3M Buy
749,659
+580,746
+344% +$13.7M 0.18% 80
2021
Q1
$3.14M Buy
+168,913
New +$3.81M 0.03% 177
2020
Q2
Sell
-37,578
Closed -$716K 431
2020
Q1
$716K Sell
37,578
-20,382
-35% -$505K 0.01% 242
2019
Q4
$1.57M Buy
+57,960
New +$1.56M 0.02% 218

Other funds holding AFYA

Pendal Group's AFYA Position: Q4 2022 in Review

Pendal Group increased its Afya (AFYA) stake by 3.2% in Q4 2022, buying an estimated $457K and bringing the position to 991,207 shares worth $15.5M. The position accounts for 0.13% of the portfolio, ranked #104.

Pendal Group first reported a position in AFYA in Q4 2019 and has held it in 9 quarters since. The position peaked at $19.3M in Q2 2021. 72 funds tracked by Wall St. Rank hold AFYA as of Q4 2022.

  • Pendal Group held 991,207 shares of Afya worth $15.5M as of Q4 2022.
  • Pendal Group bought 30,768 Afya shares in Q4 2022, an estimated $457K.
  • Afya made up 0.13% of Pendal Group's portfolio in Q4 2022, its #104 holding.
  • Pendal Group first reported a position in Afya in Q4 2019 and has held it in 9 quarters since.
  • Pendal Group's Afya position peaked at $19.3M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Afya as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.